Peter R. Carroll

Active 1982–2025

339
Papers
60,850
Citations
137
h-index
336
i10-index

Citations

Citations per year for Peter R. Carroll1936: 1 citations1980: 1 citations1984: 1 citations1985: 1 citations1986: 2 citations1987: 4 citations1988: 5 citations1989: 7 citations1990: 6 citations1991: 7 citations1992: 8 citations1993: 15 citations1994: 31 citations1995: 51 citations1996: 67 citations1997: 88 citations1998: 108 citations1999: 128 citations2000: 141 citations2001: 178 citations2002: 184 citations2003: 216 citations2004: 290 citations2005: 316 citations2006: 331 citations2007: 347 citations2008: 407 citations2009: 378 citations2010: 441 citations2011: 468 citations2012: 451 citations2013: 498 citations2014: 421 citations2015: 356 citations2016: 429 citations2017: 415 citations2018: 412 citations2019: 1,413 citations2020: 1,448 citations2021: 1,597 citations2022: 1,105 citations2023: 858 citations2024: 1,417 citations2025: 547 citations2026: 26 citations1937–1979: no citations, so these years are not shown1981–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,727 citing papers, 31% of this breakdownUnited Kingdom: 1,251 citing papers, 6.8% of this breakdownChina: 1,156 citing papers, 6.3% of this breakdownCanada: 1,062 citing papers, 5.7% of this breakdownGermany: 1,056 citing papers, 5.7% of this breakdownItaly: 1,010 citing papers, 5.5% of this breakdownNetherlands: 688 citing papers, 3.7% of this breakdownAustralia: 637 citing papers, 3.4% of this breakdownFrance: 525 citing papers, 2.8% of this breakdownJapan: 410 citing papers, 2.2% of this breakdownSwitzerland: 397 citing papers, 2.2% of this breakdownSpain: 370 citing papers, 2% of this breakdown
0%31%Other 22.7%

Fields

  • Medicine71.5%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Computer Science1.6%
  • Immunology and Microbiology1.2%
  • Engineering0.9%
  • Health Professions0.8%
  • Other3.7%

Topics

  • Prostate Cancer Treatment and Research14.6%
  • Prostate Cancer Diagnosis and Treatment14.2%
  • Advanced Radiotherapy Techniques2.1%
  • Bladder and Urothelial Cancer Treatments2%
  • Radiopharmaceutical Chemistry and Applications1.9%
  • Cancer Genomics and Diagnostics1.7%
  • Other63.5%

Coauthors

All papers

Open in search
  1. The Molecular Taxonomy of Primary Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn J. Bubley, Eric Burks, Yaron S.N. Butterfield, M. Button, David Canes, Carlos Gilberto Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard W. Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet E. Cowan, Daniel Crain, Erin Curley, Kerstin A. David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre A. Doueik, Bettina F. Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen J. Freedland, Yao Fu, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman and 212 more - Cell 2015 cited by 3,279

  2. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy

    Authors: , , , , , , , , , , , , , - JAMA Oncology 2016 cited by 666

  3. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

    Authors: , , , , , , , , , , , , , , - Nature Communications 2022 cited by 277

  4. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 787

  5. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

    Authors: , , , , , , , , , , , , , , , , - The Journal of Urology 2021 cited by 372

  6. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 337

  7. Overdiagnosis and Overtreatment of Prostate Cancer

    Authors: , , , , , , , - European Urology 2014 cited by 960

  8. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen E. McRae, Aytekin Oto, Rosaleen B. Parsons, Nayana Patel, Peter A. Pinto, Thomas J. Polascik, Benjamin Spilseth, Juliana Starcevich, Varaha S. Tammisetti, Samir S. Taneja, Barış Türkbey, Sadhna Verma, John F. Ward, Christopher A. Warlick, A. Weinberger, Jinxing Yu, Ronald J. Zagoria, Andrew B. Rosenkrantz - Radiology 2020 cited by 411

  9. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 380

  10. Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy

    Authors: , , , , , , , , , , , , , - European Urology 2012 cited by 1,299

  11. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy

    Authors: , , , , , , , , , , , , - European Urology 2018 cited by 281

  12. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2020 cited by 208

  13. THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY

    Authors: , , , , , , - The Journal of Urology 2005 cited by 769

  14. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 cited by 279

  15. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

    Authors: , , , , , , , , , , , , , , , , , , , - European Urology 2014 cited by 670

  16. The CAPRA‐S score

    Authors: , , - Cancer 2011 cited by 450

  17. Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology

    Authors: , , , , , - Journal of Nuclear Medicine 2018 cited by 247

  18. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

    Authors: , , , , , , , , , , - The Journal of Urology 2019 cited by 244

  19. Development of a stress response therapy targeting aggressive prostate cancer

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 173

  20. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2018 cited by 211

  21. 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience

    Authors: , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 212

  22. Renal cell cancer stage migration

    Authors: , , , , - Cancer 2008 cited by 592

  23. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 110

  24. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 cited by 317